1 Molloy S, "The role of levodopa in the management of dementia with Lewy bodies" 76 : 1200-1203, 2005
2 Hansen L, "The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity" 40 : 1-8, 1990
3 Walker MP, "The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia" 177 : 252-256, 2000
4 Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia" 16 : 229-237, 2003
5 Taki J, "Significance of 123IMIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease" 18 : 453-461, 2004
6 Perry RH, "Senile dementia of Lewy body type and spectrum of Lewy body disease" 1 : 1088-, 1989
7 Oka H, "Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease" 69 : 1460-1465, 2007
8 Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies" 17 : 146-157, 2004
9 Boeve BF, "REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease" 51 : 363-370, 1998
10 Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder" 72 : 1296-1300, 2009
1 Molloy S, "The role of levodopa in the management of dementia with Lewy bodies" 76 : 1200-1203, 2005
2 Hansen L, "The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity" 40 : 1-8, 1990
3 Walker MP, "The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia" 177 : 252-256, 2000
4 Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia" 16 : 229-237, 2003
5 Taki J, "Significance of 123IMIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease" 18 : 453-461, 2004
6 Perry RH, "Senile dementia of Lewy body type and spectrum of Lewy body disease" 1 : 1088-, 1989
7 Oka H, "Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease" 69 : 1460-1465, 2007
8 Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies" 17 : 146-157, 2004
9 Boeve BF, "REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease" 51 : 363-370, 1998
10 Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder" 72 : 1296-1300, 2009
11 O’Brien JT, "Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia" 56 : 1386-1388, 2001
12 Kosaka K, "Presenile dementia with Alzheimer-, Pick- and Lewy-body changes" 36 : 221-233, 1976
13 Duda JE, "Pathology and neurotransmitter abnormalities of dementia with Lewy bodies" 17 (17): 3-14, 2004
14 McKeith IG, "Operational criteria for senile dementia of Lewy body type (SDLT)" 22 : 911-922, 1992
15 Lobotesis K, "Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD" 56 : 643-649, 2001
16 Imamura T, "Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography" 12 : 194-197, 2001
17 McKeith I, "Neuroleptic sensitivity in patients with senile dementia of Lewy body type" 305 : 673-678, 1992
18 Aarsland D, "Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias" 66 : 633-637, 2005
19 Emre M, "Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo- controlled trial" 9 : 969-977, 2010
20 Boeve BF, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients" 4 : 281-284, 2003
21 Hashimoto M, "Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study" 51 : 357-362, 1998
22 Hansen LA, "Lewy body disease" 5 : 889-894, 1992
23 Galvin JE, "Lewy body dementia: the caregiver experience of clinical care" 16 : 388-392, 2010
24 Galvin JE, "Lewy body dementia: caregiver burden and unmet needs" 24 : 177-181, 2010
25 Kosaka K, "Lewy bodies in cerebral cortex, report of three cases" 42 : 127-134, 1978
26 Lucetti C, "Levodopa response in dementia with lewy bodies: a 1-year followup study" 16 : 522-526, 2010
27 Bonelli SB, "L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia" 63 : 376-378, 2004
28 Graff-Radford J, "Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies" 135 (135): 2470-2477, 2012
29 Arnulf I, "Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis" 55 : 281-288, 2000
30 Holdorff B., "Friedrich Heinrich Lewy (1885-1950) and his work" 11 : 19-28, 2002
31 Imamura T, "Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer’s disease" 7 : 77-79, 2000
32 Burn DJ, "Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study" 18 : 884-889, 2003
33 McKeith I, "Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study" 356 : 2031-2036, 2000
34 Edwards K, "Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study" 23 : 401-405, 2007
35 Briel RC, "EEG findings in dementia with Lewy bodies and Alzheimer’s disease" 66 : 401-403, 1999
36 Mori E, "Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial" 72 : 41-52, 2012
37 Kosaka K, "Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease" 3 : 185-192, 1984
38 Okazaki H, "Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion" 20 : 237-244, 1961
39 Lennox G, "Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry" 52 : 1236-1247, 1989
40 Lennox G, "Diffuse Lewy body disease" 1 : 323-324, 1989
41 Walker Z, "Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand" 73 : 134-140, 2002
42 McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium" 65 : 1863-1872, 2005
43 Omerovic M, "Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor" 78 : 1052-1057, 2007
44 Bradley BF, "Dementia with Lewy bodies" 10 : 81-112, 2004
45 McKeith I, "Dementia with Lewy bodies" 3 : 19-28, 2004
46 Byrne EJ, "Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies" 1 : 501-, 1987
47 Ferman TJ, "DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging" 62 : 181-187, 2004
48 Mori T, "Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB" 66 : 935-937, 2006
49 Galasko DR, "Continnum Lifelong Learning" 13 : 69-86, 2007
50 McKeith IG, "Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop" 47 : 1113-1124, 1996
51 Ricci M, "Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD)" 49 : e101-e104, 2009
52 Gibb WR, "Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia)" 110 (110): 1131-1153, 1987
53 Schenck CH, "Chronic behavioral disorders of human REM sleep: a new category of parasomnia" 9 : 293-308, 1986
54 Orimo S, "Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease" 109 : 583-588, 2005
55 Donnemiller E, "Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease" 24 : 320-325, 1997
56 Swanberg MM, "Benefit-risk considerations in the treatment of dementia with Lewy bodies" 25 : 511-523, 2002
57 Borroni B, "Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment" 46 : 101-106, 2008
58 Cousins DA, "Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study" 61 : 1191-1195, 2003
59 Zaccai J, "A systematic review of prevalence and incidence studies of dementia with Lewy bodies" 34 : 561-566, 2005
60 Barber R, "A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer’s disease: magnetic resonance imaging volumetric study" 12 : 198-205, 2001
61 Yoshita M, "A clinical role for [(123)I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer’s-type and dementia with Lewy bodies" 71 : 583-588, 2001
62 Whitworth HB, "A caregiver’s guide to Lewy body dementia" Demoshealth 37-40, 2011